Laursen, Natasha https://orcid.org/0009-0000-6740-3072
Sølling, Anne Sophie
Harsløf, Torben
Langdahl, Bente
Article History
Received: 19 September 2024
Accepted: 10 December 2024
First Online: 8 January 2025
Declarations
:
: ASS has received lecture fees from Amgen. TH has received speaker fees from UCB, Amgen, AstraZeneca and Astellas Pharma. BL has received lectures fees from Amgen and serves as a consultant for UCB, Mereo and Samsung-Bioepis. NL declares no conflict of interest.